Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Castillo SS and Teegarden D Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells. 2001 J. Nutr. pmid:11694603
Lyons JM and Karin NJ A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells. 2001 J. Bone Miner. Res. pmid:11697799
Hornuss C et al. Human and rat alveolar macrophages express multiple EDG receptors. 2001 Eur. J. Pharmacol. pmid:11698050
Yoshida A and Ueda H Neurobiology of the Edg2 lysophosphatidic acid receptor. 2001 Jpn. J. Pharmacol. pmid:11700008
Im DS et al. Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors. 2001 Biochemistry pmid:11705398
Rosenfeldt HM et al. The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility. 2001 Biochem. Soc. Trans. pmid:11709084
Manggau M et al. 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. 2001 J. Invest. Dermatol. pmid:11710939
Tigyi G Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family. 2001 Mol. Pharmacol. pmid:11723220
Rosenfeldt HM et al. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. 2001 FASEB J. pmid:11726541
Lampasso JD et al. Sphingosine-1-phosphate effects on PKC isoform expression in human osteoblastic cells. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728164
Hla T et al. Lysophospholipids--receptor revelations. 2001 Science pmid:11729304
Muraki K and Imaizumi Y A novel function of sphingosine-1-phosphate to activate a non-selective cation channel in human endothelial cells. 2001 J. Physiol. (Lond.) pmid:11731576
Tosaka M et al. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. 2001 Stroke pmid:11739995
Alemany R et al. Depolarisation induces rapid and transient formation of intracellular sphingosine-1-phosphate. 2001 FEBS Lett. pmid:11741596
Ancellin N et al. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. 2002 J. Biol. Chem. pmid:11741921
Porcelli AM et al. Phospholipase D stimulation is required for sphingosine-1-phosphate activation of actin stress fibre assembly in human airway epithelial cells. 2002 Cell. Signal. pmid:11747992
Sullards MC and Merrill AH Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. 2001 Sci. STKE pmid:11752637
Okajima F [Establishment of the method for the measurement of sphingosine-1-phosphate in biological samples and its application for S1P research]. 2001 Nippon Yakurigaku Zasshi pmid:11778456
Rikitake Y et al. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. 2002 Arterioscler. Thromb. Vasc. Biol. pmid:11788469
Benaud C et al. Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. 2002 J. Biol. Chem. pmid:11792696
Ohanian J and Ohanian V Sphingolipids in mammalian cell signalling. 2001 Cell. Mol. Life Sci. pmid:11814056
Gennero I et al. Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density. 2002 J. Biol. Chem. pmid:11821388
Meacci E et al. Sphingosine 1-phosphate evokes calcium signals in C2C12 myoblasts via Edg3 and Edg5 receptors. 2002 Biochem. J. pmid:11853542
Chin TY et al. Distinct effects of different calcium-mobilizing agents on cell death in NG108-15 neuroblastoma X glioma cells. 2002 Mol. Pharmacol. pmid:11854428
Lee M and Han SS Choline phosphate potentiates sphingosine-1-phosphate-induced Raf-1 kinase activation dependent of Ras--phosphatidylinositol-3-kinase pathway. 2002 Cell. Signal. pmid:11858945
Ryu Y et al. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. 2002 Circ. Res. pmid:11861422
English D Do platelet-released phospholipids play a role in cardiovascular malformations and heritable coangulopathies? 2002 Teratology pmid:11877771
Baumruker T and Prieschl EE Sphingolipids and the regulation of the immune response. 2002 Semin. Immunol. pmid:11884231
Weiner OD Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. 2002 Curr. Opin. Cell Biol. pmid:11891119
Boguslawski G et al. Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response. 2002 Exp. Cell Res. pmid:11900487
Kihara A and Igarashi Y [Sphingosine 1-phosphate in yeast]. 2002 Tanpakushitsu Kakusan Koso pmid:11915338
Okazaki T and Ito M [Signal transduction of ceramide]. 2002 Tanpakushitsu Kakusan Koso pmid:11915339
Igarashi Y [Current studies on a novel lipid mediator, sphingosine 1-phosphate, and its receptors]. 2002 Tanpakushitsu Kakusan Koso pmid:11915345
Okajima F [Distribution of sphingosine 1-phosphate in plasma lipoproteins and its role in the regulation of the vascular cell functions]. 2002 Tanpakushitsu Kakusan Koso pmid:11915346
Yatomi Y et al. [Sphingosine 1-phosphate and vascular endothelial cells]. 2002 Tanpakushitsu Kakusan Koso pmid:11915347
Takuwa Y [Regulation of Rho family G proteins and cell motility by the Edg family of sphingosin 1-phosphate receptors]. 2002 Tanpakushitsu Kakusan Koso pmid:11915348
Tsukahara T et al. [Molecular diversity of sphingosine kinase]. 2002 Tanpakushitsu Kakusan Koso pmid:11915350
Hanafusa N et al. Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. 2002 Nephrol. Dial. Transplant. pmid:11917049
Idzko M et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. 2002 FASEB J. pmid:11919175
Mandala S et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. 2002 Science pmid:11923495
Schilling T et al. Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca(2+)-dependent K(+) channels. 2002 Neuroscience pmid:11927165
Sano T et al. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. 2002 J. Biol. Chem. pmid:11929870
Aas V et al. Fibronectin promotes calcium signaling by interferon-gamma in human neutrophils via G-protein and sphingosine kinase-dependent mechanisms. 2001 Cell Commun. Adhes. pmid:11936187
Min JK et al. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. 2002 Anal. Biochem. pmid:11950216
Essler M et al. Sphingosine 1-phosphate dynamically regulates myosin light chain phosphatase activity in human endothelial cells. 2002 Cell. Signal. pmid:11955953
Endo A et al. Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII. 2002 J. Biol. Chem. pmid:11956190
Black JL and Johnson PR Factors controlling smooth muscle proliferation and airway remodelling. 2002 Curr Opin Allergy Clin Immunol pmid:11964750
Brinkmann V et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. 2002 J. Biol. Chem. pmid:11967257
Bartholomä P et al. Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation. 2002 Biochem. Pharmacol. pmid:11996893
Formigli L et al. Sphingosine 1-phosphate induces Ca2+ transients and cytoskeletal rearrangement in C2C12 myoblastic cells. 2002 Am. J. Physiol., Cell Physiol. pmid:11997251